1991
DOI: 10.1152/ajprenal.1991.261.2.f345
|View full text |Cite
|
Sign up to set email alerts
|

Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus

Abstract: To test the hypothesis that rapid adenosine 3',5'-cyclic monophosphate (cAMP) catabolism via cyclic 3',5'-nucleotide phosphodiesterase (PDE) is a cause of the unresponsiveness to vasopressin (VP) in mice with hereditary nephrogenic diabetes insipidus (NDI), we investigated properties of PDEs and other aspects of the VP-dependent cAMP-signaling system in segments of collecting ducts [inner medullary (IMCD), cortical (CCD), and outer medullary (OMCD) ducts] microdissected from control mice and mice with NDI. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
27
0

Year Published

1992
1992
2013
2013

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(28 citation statements)
references
References 0 publications
1
27
0
Order By: Relevance
“…In addition, when forskolin is used to stimulate directly the catalytic subunit of adenylyl cyclase (18), it significantly increases UT-A1 accumulation in the plasma membrane in IMCD suspensions from either basal or hydrated rats. Because collecting ducts in general are known to be conditioned in polyuric rats and their cAMP response to vasopressin is subdued (17,40,41), we speculate that the failure to detect an increase in UT-A1 accumulation after vasopressin administration in the Brattleboro rat (16) or our hydrated Sprague-Dawley rats may have resulted from an insufficient cAMP response. However, in Sprague-Dawley rats with a presumably normal cAMP response to vasopressin or when forskolin is used as the agonist, increases in both UT-A1 and AQP2 accumulation in the plasma membrane are clearly detected.…”
Section: Discussionmentioning
confidence: 88%
“…In addition, when forskolin is used to stimulate directly the catalytic subunit of adenylyl cyclase (18), it significantly increases UT-A1 accumulation in the plasma membrane in IMCD suspensions from either basal or hydrated rats. Because collecting ducts in general are known to be conditioned in polyuric rats and their cAMP response to vasopressin is subdued (17,40,41), we speculate that the failure to detect an increase in UT-A1 accumulation after vasopressin administration in the Brattleboro rat (16) or our hydrated Sprague-Dawley rats may have resulted from an insufficient cAMP response. However, in Sprague-Dawley rats with a presumably normal cAMP response to vasopressin or when forskolin is used as the agonist, increases in both UT-A1 and AQP2 accumulation in the plasma membrane are clearly detected.…”
Section: Discussionmentioning
confidence: 88%
“…Mice with genetically increased activity of PDE3 and PDE4 show a fourfold higher PDE activity in microdissected IMCD and cortical CD and lack an increase in cAMP in response to V 2 R activation, which is associated with lower AQP2 mRNA and protein expression and lower urine osmolality. 23,24 Pharmacologic studies have argued against a role of PDE3 in urine osmolality. 25 However, treatment of mutant AQP2 heterozygous knock-in mice or mice with hereditary NDI with the PDE4 inhibitor, rolipram, increases urine osmolality and restores AVP-dependent cAMP accumulation in IMCD, indicating a role for PDE4 in the regulation of cAMP and urinary concentration.…”
Section: Discussionmentioning
confidence: 99%
“…13,14 Similarly, although AQP2 protein is preserved in the vasopressin-deficient Brattleboro rat (with spontaneous mutation of the vasopressin gene leading to "central" DI) or mice with overactive cAMP phosphodiesterase in principal cells, both have polyuria from birth without tubular/renal malformation or kidney failure. 15,16 Interestingly, several other mouse models in which polyuria is associated with perturbations in renal structure are reported to have greatly reduced AQP2 expression, whereas polyuric models with no structural abnormalities have normal AQP2 levels. 14,[17][18][19][20][21][22] Thus, we hypothesized that the tubular abnormalities seen in the neonatal AQP2 knockout animals and/or AQP2 transgenics are due to an intrinsic defect associated with the absence or dysfunction of AQP2 rather than being a secondary effect of polyuria.…”
mentioning
confidence: 99%